Owing to their use in the manufacturing of biologics and biosimilars, and various application areas, such as drug screening, gene functional studies, cell-based assay development, diagnostics and tissue engineering, there is growing demand for different types of cell lines. The ‘Cell Line Development Services Market, 2017 – 2027’ report provides an extensive study of the rapidly growing market of cell lines. Mentioned below are a few key takeaways from the report.
US and EU: The Key Service Hubs
Approximately 80% of the players are located in North America and the EU; within Asia Pacific, China and India have emerged as popular hubs.
Fragmented, But Well-Distributed, Market Landscape
Both well-established and mid-sized players, and start-ups, are actively involved in the development and production of cell lines.
Multiple Cell Line Procurement Sources for a Range of Applications
High-yielding cell lines can be derived from multiple sources and, given the evolution of the biopharmaceutical market, are being used for several purposes
Service Providers Aiming for Expansion …
Companies are rapidly expanding their service offerings and technology platforms in order to maintain a competitive edge in the market
… Are Gradually Widening Services Portfolio
In fact, several players already provide affiliated services, such as cell line characterization and cell banking, as integral parts of their respective services portfolios
A Steadily Growing Billion Dollar Market
Driven by the robust and promising pipeline of biotherapeutics, the cell line development services market is anticipated to witness steady growth in the coming decade.
Emerging Novel and Innovative Technologies
The heightened competition and growing demand for cell lines has resulted in the emergence of several novel and innovative technologies, lowering of manufacturing costs and production timelines. Examples of some companies that have developed proprietary technologies for production of cell lines include (in alphabetical order) Abzena (Composite CHO™ technology), ACROBiosystems (HEKMax® Stable Cell Line Technology), BioFactura (StableFast™ Biomanufacturing Platform), Batavia Biosciences (STEP® technology), Celltheon (SMART™ expression platform), Celonic (CHOvolution™ / SEFEX platform), Cevec Pharmaceuticals (CAP®GO platform) and Selexis (SUREtechnology Platform™)
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.